Donaco International Limited engages in leisure and entertainment businesses in the Asia Pacific region. More Details
Adequate balance sheet and overvalued.
Share Price & News
How has Donaco International's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: DNA is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 10% a week.
Volatility Over Time: DNA's weekly volatility (10%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: DNA underperformed the Australian Hospitality industry which returned 50.6% over the past year.
Return vs Market: DNA underperformed the Australian Market which returned 26% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Donaco International's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall StIs Donaco International (ASX:DNA) A Risky Investment?
5 months ago | Simply Wall StHow Much Did Donaco International's(ASX:DNA) Shareholders Earn From Share Price Movements Over The Last Five Years?
Is Donaco International undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate DNA's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate DNA's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: DNA is unprofitable, so we can't compare its PE Ratio to the Australian Hospitality industry average.
PE vs Market: DNA is unprofitable, so we can't compare its PE Ratio to the Australian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate DNA's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: DNA is good value based on its PB Ratio (0.2x) compared to the AU Hospitality industry average (2.5x).
How is Donaco International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Consumer Services industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Donaco International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Donaco International performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: DNA is currently unprofitable.
Growing Profit Margin: DNA is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: DNA is unprofitable, and losses have increased over the past 5 years at a rate of 42.9% per year.
Accelerating Growth: Unable to compare DNA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DNA is unprofitable, making it difficult to compare its past year earnings growth to the Hospitality industry (2.1%).
Return on Equity
High ROE: DNA has a negative Return on Equity (-8.44%), as it is currently unprofitable.
How is Donaco International's financial position?
Financial Position Analysis
Short Term Liabilities: DNA's short term assets (A$15.7M) do not cover its short term liabilities (A$32.4M).
Long Term Liabilities: DNA's short term assets (A$15.7M) exceed its long term liabilities (A$7.5M).
Debt to Equity History and Analysis
Debt Level: DNA's debt to equity ratio (6.6%) is considered satisfactory.
Reducing Debt: DNA's debt to equity ratio has reduced from 37.3% to 6.6% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: DNA has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: DNA has less than a year of cash runway if free cash flow continues to reduce at historical rates of 8% each year
What is Donaco International current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate DNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if DNA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DNA's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: DNA is not paying a notable dividend for the Australian market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of DNA's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Techatut Sukcharoenkraisri Huy
Mr. Lee Bug Huy, also known as Techatut Sukcharoenkraisri, serves as Chief Executive Officer and Executive Director at Donaco International Limited since September 03, 2020. He was Non-Executive Director a...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Techatut Sukcharoenkraisri's total compensation is reasonable compared to companies of similar size in the Australian market.
Compensation vs Earnings: Techatut Sukcharoenkraisri's compensation has increased whilst the company is unprofitable.
Experienced Management: DNA's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Experienced Board: DNA's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 50%.
Donaco International Limited's company bio, employee growth, exchange listings and data sources
- Name: Donaco International Limited
- Ticker: DNA
- Exchange: ASX
- Founded: 1990
- Industry: Casinos and Gaming
- Sector: Consumer Services
- Market Cap: AU$46.945m
- Shares outstanding: 1.24b
- Website: https://www.donacointernational.com
- Donaco International Limited
- Martin Place
- Level 43
- New South Wales
Donaco International Limited engages in leisure and entertainment businesses in the Asia Pacific region. It operates Star Vegas Resort & Club, a casino and hotel complex comprising approximately 100 gaming...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/27 08:22|
|End of Day Share Price||2021/07/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.